125 related articles for article (PubMed ID: 15716602)
1. Expression of CD99 in pleomorphic carcinomas of the lung.
Yoo SH; Han J; Kim TJ; Chung DH
J Korean Med Sci; 2005 Feb; 20(1):50-5. PubMed ID: 15716602
[TBL] [Abstract][Full Text] [Related]
2. Pulmonary carcinomas with pleomorphic, sarcomatoid, or sarcomatous elements: a clinicopathologic and immunohistochemical study of 75 cases.
Rossi G; Cavazza A; Sturm N; Migaldi M; Facciolongo N; Longo L; Maiorana A; Brambilla E
Am J Surg Pathol; 2003 Mar; 27(3):311-24. PubMed ID: 12604887
[TBL] [Abstract][Full Text] [Related]
3. Cytokeratin 7 and 20 and thyroid transcription factor 1 can help distinguish pulmonary from gastrointestinal carcinoid and pancreatic endocrine tumors.
Cai YC; Banner B; Glickman J; Odze RD
Hum Pathol; 2001 Oct; 32(10):1087-93. PubMed ID: 11679943
[TBL] [Abstract][Full Text] [Related]
4. Differential expression of cytokeratins 7 and 20 and thyroid transcription factor-1 in bronchioloalveolar carcinoma: an immunohistochemical study in fine-needle aspiration biopsy specimens.
Simsir A; Wei XJ; Yee H; Moreira A; Cangiarella J
Am J Clin Pathol; 2004 Mar; 121(3):350-7. PubMed ID: 15023039
[TBL] [Abstract][Full Text] [Related]
5. [Value of thyroid transcription factor-1 in identification of the prognosis of bronchioloalveolar carcinoma].
Wang CL; Yue DS; Zhang ZF; Zhan ZL; Sun LN
Zhonghua Yi Xue Za Zhi; 2007 Sep; 87(33):2350-4. PubMed ID: 18036300
[TBL] [Abstract][Full Text] [Related]
6. Expression of thyroid transcription factor-1, cytokeratin 7, and cytokeratin 20 in bronchioloalveolar carcinomas: an immunohistochemical evaluation of 67 cases.
Lau SK; Desrochers MJ; Luthringer DJ
Mod Pathol; 2002 May; 15(5):538-42. PubMed ID: 12011259
[TBL] [Abstract][Full Text] [Related]
7. Clinicopathological and immunohistochemical analysis of 20 cases of Merkel cell carcinoma in search of prognostic markers.
Llombart B; Monteagudo C; López-Guerrero JA; Carda C; Jorda E; Sanmartín O; Almenar S; Molina I; Martín JM; Llombart-Bosch A
Histopathology; 2005 Jun; 46(6):622-34. PubMed ID: 15910593
[TBL] [Abstract][Full Text] [Related]
8. Usefulness of Cdx2 in separating mucinous bronchioloalveolar adenocarcinoma of the lung from metastatic mucinous colorectal adenocarcinoma.
Saad RS; Cho P; Silverman JF; Liu Y
Am J Clin Pathol; 2004 Sep; 122(3):421-7. PubMed ID: 15362373
[TBL] [Abstract][Full Text] [Related]
9. Thyroid transcription factor-1 and cytokeratins 7 and 20 in pulmonary and breast carcinoma.
Harlamert HA; Mira J; Bejarano PA; Baughman RP; Miller MA; Whitsett JA; Yassin R
Acta Cytol; 1998; 42(6):1382-8. PubMed ID: 9850647
[TBL] [Abstract][Full Text] [Related]
10. The value of immunohistochemical expression of TTF-1, CK7 and CK20 in the diagnosis of primary and secondary lung carcinomas.
Al-Zahrani IH
Saudi Med J; 2008 Jul; 29(7):957-61. PubMed ID: 18626520
[TBL] [Abstract][Full Text] [Related]
11. Role of TTF-1, CK20, and CK7 immunohistochemistry for diagnosis of primary and secondary lung adenocarcinoma.
Su YC; Hsu YC; Chai CY
Kaohsiung J Med Sci; 2006 Jan; 22(1):14-9. PubMed ID: 16570563
[TBL] [Abstract][Full Text] [Related]
12. Histopathologic classification of lung cancer: Relevance of cytokeratin and TTF-1 immunophenotyping.
Johansson L
Ann Diagn Pathol; 2004 Oct; 8(5):259-67. PubMed ID: 15494931
[TBL] [Abstract][Full Text] [Related]
13. CD99 expression in Merkel cell carcinoma: a case series with an unusual paranuclear dot-like staining pattern.
Rajagopalan A; Browning D; Salama S
J Cutan Pathol; 2013 Jan; 40(1):19-24. PubMed ID: 23145531
[TBL] [Abstract][Full Text] [Related]
14. Identifying colorectal metastases in liver biopsies: the novel CDX2 antibody is less specific than the cytokeratin 20+/7- phenotype.
Tot T
Med Sci Monit; 2004 May; 10(5):BR139-43. PubMed ID: 15114262
[TBL] [Abstract][Full Text] [Related]
15. Thyroid transcription factor-1, thyroglobulin, cytokeratin 7, and cytokeratin 20 in thyroid neoplasms.
Bejarano PA; Nikiforov YE; Swenson ES; Biddinger PW
Appl Immunohistochem Mol Morphol; 2000 Sep; 8(3):189-94. PubMed ID: 10981870
[TBL] [Abstract][Full Text] [Related]
16. Expression of cytokeratin 7 and 20 in pathological conditions of the bile tract.
Cabibi D; Licata A; Barresi E; Craxì A; Aragona F
Pathol Res Pract; 2003; 199(2):65-70. PubMed ID: 12747467
[TBL] [Abstract][Full Text] [Related]
17. Utility of thyroid transcription factor-1 and cytokeratin 7 and 20 immunostaining in the identification of origin in malignant effusions.
Jang KY; Kang MJ; Lee DG; Chung MJ
Anal Quant Cytol Histol; 2001 Dec; 23(6):400-4. PubMed ID: 11777274
[TBL] [Abstract][Full Text] [Related]
18. Variable expression of keratins and nearly uniform lack of thyroid transcription factor 1 in thyroid anaplastic carcinoma.
Miettinen M; Franssila KO
Hum Pathol; 2000 Sep; 31(9):1139-45. PubMed ID: 11014583
[TBL] [Abstract][Full Text] [Related]
19. Thyroid transcription factor 1 expression in small cell carcinoma of the urinary bladder: an immunohistochemical profile of 44 cases.
Jones TD; Kernek KM; Yang XJ; Lopez-Beltran A; MacLennan GT; Eble JN; Lin H; Pan CX; Tretiakova M; Baldridge LA; Cheng L
Hum Pathol; 2005 Jul; 36(7):718-23. PubMed ID: 16084939
[TBL] [Abstract][Full Text] [Related]
20. Immunohistochemical distinction between merkel cell carcinoma and small cell carcinoma of the lung.
Bobos M; Hytiroglou P; Kostopoulos I; Karkavelas G; Papadimitriou CS
Am J Dermatopathol; 2006 Apr; 28(2):99-104. PubMed ID: 16625069
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
